According to the announcement from Zhitong Finance APP, ER-KANG (300267.SZ) has released a notice stating that the company's board of directors has approved the proposal regarding the construction of a comprehensive formulation production project by its subsidiary, ER-KANG Tanzania Limited. The company has agreed to allow its holding subsidiary, ER-KANG Tanzania Limited, to use self-raised funds of USD 10 million to invest in the construction of the comprehensive formulation production project, with a construction period of 12 months.

This project investment is a deployment and arrangement necessary for the company's overall development strategy. By expanding the investment layout of overseas projects, it is beneficial to further broaden the company's business radiation range, meet the needs of overseas customers, improve the company's economic benefits, and enhance the company's overall competitiveness